VPRIV DIN 02357119
Health Canada record
| Active ingredient(s) | VELAGLUCERASE ALFA 400 UNIT |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | A16AB10 VELAGLUCERASE ALFA |
| Original market date | 22-Nov-2010 |
| Current status date | 15-Oct-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Takeda Canada Inc. — licence 101769, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11783 | 2010-10-01 | New Drug Submission (NDS) |